GERM News and Press, ETFMG Treatments Testing and Advancements From 10/18/23

2023-10-18 21:49:00 ET Summary After many years of Cumberland’s US Equity ETF portfolios being overweight in the healthcare sector, we are now at our lowest relative market weight for a long time. The economic benefits to the sector from the Covid pandemic are over. The...

2023-10-10 07:16:00 ET Summary European countries have been plagued by a persistent medicine shortage for the past few years. Supply chain disruptions and increased demand are driving the shortfall. There are potential solutions; and one could involve breeding a whole lot more...

2023-09-29 23:45:00 ET Summary A combination of public and private investments in neuroscience, government grants, and charitable donations are helping accelerate a wave of advancements and opportunities in neuroscience. Recent clinical trial success for the second significant, di...

2023-09-23 01:19:25 ET More on ETFMG Treatments, Testing and Advancements ETF Dividend scorecard for ETFMG Treatments, Testing and Advancements ETF For further details see: ETFMG Treatments, Testing and Advancements ETF declares quarterly distribution of $0.0400

2023-09-22 03:30:00 ET Summary Healthcare stocks often serve as powerful painkillers during market declines. While the MSCI World Index fell by 18.1% in 2022, healthcare stocks fell by only 5.4%. Investing effectively in healthcare stocks requires a unique set of skills. ...

2023-08-16 02:28:00 ET Summary Risk-on sentiment and end of pandemic boom have weighed on healthcare. Health insurers and medical device firms have held up better. Growing opportunity in obesity treatments. Tarik Aeta, Global Healthcare Analyst with TD Asset Mana...

2023-08-11 01:45:00 ET Summary The U.S. healthcare system remains a global outlier in both innovation and cost. The U.S. spends twice as much per capita on healthcare versus its developed-country peers yet life expectancy is lower by 6.3 years. Healthcare companies continue to...

2023-07-25 04:17:00 ET Summary Over the last seven recessionary periods in the U.S., healthcare outperformed the broader market by an average of 10%. Slowing economies call for the resilience that healthcare companies can offer, yet the sector remains at a 10% discount to global e...

2023-07-25 01:30:00 ET Summary Why the stock market gains we're seeing may not be telling the whole story. Investors may have been too focused on market capitalization in the first half. Finding opportunities in the healthcare sector. The strong market performance ...

2023-07-24 22:24:00 ET Summary Equity and fixed income markets experienced heightened volatility amid the Q2 debt-ceiling saga, while currency and derivatives markets were mostly unaffected. Regional banks struggled in Q2, with deposits and witnessed credit spreads widening by 100...